IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 21 a 40 di 136
Titolo Data di pubblicazione Autore(i) File
Drug combination Of AZT And Ddi: Synergism Of Action And Prevention of Appearance of AZT-Resistance 1-gen-1994 Antonelli, G; Dianzani, F; Bellarosa, D; Turriziani, O; Riva, E; Gentile, A.
Biological and clinical significance of neutralizing and binding antibodies to interferon-alpha (IFN-alpha) during therapy for chronic hepatitis C. 1-gen-1994 Giannelli, G; Antonelli, G; Fera, G; Del Vecchio, S; Riva, E; Broccia, C; Schiraldi, O; Dianzani, F.
Infectious virus with reduced cytopathogenicity resulting from persistent infection of normal lung fibroblasts by HIV type 1 strains. 1-gen-1994 Dolei, A; Serra, C; Arca, Mv; Tilocca, F; Riva, E; Antonelli, G; Dianzani, F; Toniolo, A.
Identification of an amino acid substitution involved in the reduction of sensitivity of HIV-1 to an inhibitor of viral proteinase. 1-gen-1994 Turriziani, O; Antonelli, G; Jacobsen, H; Mous, J; Riva, E; Pistello, M; Dianzani, F.
Resistenza dell'HIV-1 ai farmaci antiretrovirali: considerazioni biologiche e cliniche. 1-gen-1995 G., Antonelli; O., Turriziani; Riva, E; F., Dianzani
Fattori di non progressione nell'infezione da HIV. 1-gen-1995 R., Paganelli; E., Scala; R., Ferrara; R., Rosso; M., Carlesimo; Ar., Varani; M., Pierdominici; A., Antinori; G., Antonelli; Riva, E; V., Giannini; G., Visco; V., Vullo; M. Falciano e G., D'Offizi
vitro selection of HIV-1 resistance to ddI is no as efficient as for the other antiretroviral drugs and yields virus which shows reduced cytophatic activity. 1-gen-1995 Dianzani, F; Antonelli, G; Bellarosa, D; Bambacioni, F; Riva, E; Turriziani, O
The prolonged treatment with AZT may induce, in vitro and in vivo, a defect of thymidine kinase activity. 1-gen-1995 Antonelli, G; Turriziani, O; Tozzi, V; D’Offizi, G; Verri, A; Riva, E; Dianzani, F
Alteration of thymidine kinase activity in cells treated with an antiviral agent. 1-gen-1995 Turriziani, O; Antonelli, G; Verri, A; Tozzi, V; Ferri, F; Riva, E; Bambacioni, F; Dianzani, F.
Cellular factors leading to AZT resistance of HIV. 1-gen-1995 ., Dianzani; O., Turriziani; Riva, E; F., Bambacioni; M., Solmone; E., Simeoni; C., Barresi; P., Di Marco; M., Gitto; Mr., Capobian¬chi; G., Antonelli
Immunological And Virological Studies In Long-Term Non-Progressor HIV Infected Individuals. 1-gen-1995 Riva, Elisabetta
Scalpel injury and HIV infection in a surgeon 1-gen-1996 Riva, Elisabetta
Plasma HIV viremia and viral load in lymph nodes 1-gen-1996 Dianzani, F; Antonelli, G; Riva, E; Uccini S and Visco, G.
Immunological characterization of Long-Term Nonprogressive HIV-1 infection 1-gen-1997 G., D’ Offizi; R., Paganelli; E., Scala; F. Aiuti and the NOPHROCO Study Group (NOPHROCO) Dianzani, F.; Riva, E; G., Antonelli; R., Paganelli; R., Ferrara; E., Scala; M., Pierdominici; Ar., Varani; M., Carlesimo; R., Rosso; A., Oliva; C., Alario; L., Palmieri; G., Visco
Anti-interferon (IFN) antibodies in patients with relapsing remitting multipla sclerosis treated with recombinant IFN1a or IFN1b 1-gen-1998 Antonelli, G; Simeoni, E; Bagnato, F; Pozzilli, P; Currenti, M; Di Marco, P; Turriziani, O; Riva, E; Gasperini, C; Dianzani, F; Fieschi, C
In vivo MXA m RNA expression as predictive marker of response to IFNin chronic active hepatitis patients. 1-gen-1998 Antonelli, G; Turriziani, O; Simeoni, E; Tesoro, R; Riva, E; Nava, C; Roffi, L; Antonelli, L; Brogi, A; Maggi, F; Pistello, M; Dianzani, F
The benign cystic lymphoepitelial lesion of the parotid gland is a viral reservoir in HIV-1 infected patients 1-gen-1999 S., Uccini; Riva, E; G., Antonelli; G., Doffizi; A., Prozzo; A., Angelici; A., Faggioni; A., Angeloni; Mr., Torrisi; M., Gentile; P., Ruco; Cd., Baroni
Influence of Hepatitis C virus (HCV) genotype, HCV RNA load and ALT level on reduction of HCV RNA after a single administration of interferon alpha 1-gen-1999 Antonelli, G; Riva, E; Maggi, F; Vatteroni, Ml; Simeoni, E.
SIGNIFICANT REDUCTION IN HIV-1 PLASMA VIRAL LOAD BUT NOT IN PROVIRAL INFECTED CELLS DURING SUB-OPTIMAL ANTIRETROVIRAL THERAPY 1-gen-2000 Riva, E; G., Antonelli; Mc., Solmone; O., Turriziani; P., Narciso; V., Tozzi; F., Dianzani.
THE NUMBER OF HIV DNA-INFECTED MONONUCLEAR CELLS IS REDUCED UNDER HAART PLUS RECOMBINANT IL-2 1-gen-2000 F., Dianzani; G., Antonelli; F., Aiuti; O., Turriziani; Riva, E; Mr., Capobianchi; F., Pandolfi; G., Doffizi; IRHAN STUDY, Group.
Mostrati risultati da 21 a 40 di 136
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile